Europe Diagnostics Market By Product (Instruments, Reagents, Software & Services), By Technology (Immunoassay, Hematology, Clinical Chemistry, Molecular Diagnostics, Microbiology, Others), By Application (Infectious Diseases, Diabetes, Oncology, Cardiology, Nephrology, Others), By End User (Hospitals & Clinics, Diagnostic Centers & Laboratories, Others), By Country, Competition, Forecast & Opportunities, 2028

Europe diagnostics market is expected to grow at an impressive rate during the forecast period, 2024-2028. Growing incidences of various diseases along with extensive technological advancements in the country is likely to propel the growth of the market. Clinical diagnostics has open up new possibilities for early prevention and intervention by identifying the risk factors and early warning indications in a patient. As a result, it is projected that the entire market would continue to grow as the occurrences of chronic illnesses rises. Also, there is an increase in In-vitro diagnostic tests as well as increasing demand for genetic testing, which, in turn is surging the growth of the market.

Additionally, growing demand for Point-of-Care testing is a major factor for the market’s growth. This can be attributed to surging demand for self-testing diagnostics, and also the patient awareness regarding early diagnosis of the diseases. The growing popularity of personalized medicine among people for the treatments of several chronic diseases is likely to create lucrative opportunities for market growth over the next few years.

Growing Prevalence of Several Diseases and Disorders

Growing incidences and prevalence of lifestyle disorders such as hypertension, cardiovascular diseases, cancer, diabetes, among others, is expected to bolster the growth of the market. According to the Global Cancer Observatory report, in 2020, 4,398,443 European people were suffering from cancer, out of which 1,955,231 people lost their lives due to cancer. Additionally, people are becoming more aware about the early diagnosis and treatment of the chronic diseases, which, in turn, surges the demand for diagnostic tests. Therefore, these factors are anticipated to facilitate the growth of the market.

Increasing Aging Population

The rising geriatric population is increasing the risk of getting several diseases including heart strokes, cancer, cardiovascular diseases, neurological disorders, and diabetes in the country is facilitating the growth of the market. For instance, in 2021, Europe has largest proportion of the ageing population with 19%, where Germany is the country that contributed the most to the older population with 17.78 million, followed by Italy with 13.76 million, France with 13.16 million, and the United Kingdom with 12.24 million.

Recent Developments: 

• In 2021, Roche introduced its Cobas Pulse System in select countries accepting CE mark approval in Europe. The item is a networked point-of-care solution from Roche Diagnostics' latest generation. The most recent release offers expert blood glucose management.
• In 2021, Hologic announced the European launch of Genius™ Digital Diagnostics System for cervical cancer screening. It is the next generation of cervical cancer screening that merge deep learning-based artificial intelligence (AI) with advanced volumetric imaging technology to assist in identifying pre-cancerous lesions and cervical cancer cells in women. It was developed to offer actionable insights, and to improve workflow and lab efficiency, which primarily focus on eradicating cervical cancer.

Download Free Sample Report

Market Segmentation

Europe diagnostics market is segmented into product, technology, application, end user, company and region. Based on product, the market is categorized into instruments, reagents, and software & services. Based on technology, the market is divided into immunoassay, hematology, clinical chemistry, molecular diagnostics, microbiology, and others. Based on application, the market can be divided into infectious diseases, diabetes, oncology, cardiology, nephrology, and others. Based on end user, the market is bifurcated into hospitals & clinics, diagnostic centers & laboratories, and others. In term of countries, the market is segmented into France, Germany, United Kingdom, Italy, Spain, Finland, Greece, Portugal, Bulgaria, and Croatia. 

Market Players

Roche Diagnostics GmbH, Ortho Clinical Diagnostics., Abbott Laboratories, Inc., Hologic, Inc. (Gen-Probe), Qiagen N.V., Bio-Rad Laboratories, Inc., Quidel Corporation, Becton, Dickinson (BD) Company, Inc., bioMerieux, Inc., and Siemens Healthcare GmbH are some of the leading companies operating in the Europe Diagnostics Market.

Report Scope:

In this report, Europe diagnostics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

• Europe Diagnostics Market, By Product:
• Instruments
• Reagents
• Software & Services
• Europe Diagnostics Market, By Technology:
• Immunoassay
• Hematology
• Clinical Chemistry
• Molecular Diagnostics
• Microbiology
• Others
• Europe Diagnostics Market, By Application:
• Infectious Diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Others
• Europe Diagnostics Market, By End User:
• Hospitals & Clinics
• Diagnostic Centers & Laboratories
• Others
• Europe Diagnostics Market, By Country:
• France
• Germany
• United Kingdom
• Italy
• Spain
• Finland
• Greece
• Portugal
• Bulgaria
• Croatia.

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Europe diagnostics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Europe diagnostics market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]